![Hiroki Narita](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hiroki Narita
Directeur/Membre du Conseil chez
Cardio, Inc.
Profil
Hiroki Narita is currently the Director at Cardio, Inc. and the Senior Managing Director at Daiwa Corporate Investment Co., Ltd. He previously held positions as an Outside Director at REGiMMUNE Corp., an Outside Director at TMRC Co. Ltd., a Director at Ribomic, Inc., an Outside Director at RaQualia Pharma, Inc., and a Deputy General Manager at Daiwa SMBC Capital Co., Ltd. Mr. Narita completed his undergraduate degree at Aoyama Gakuin University.
Postes actifs de Hiroki Narita
| Sociétés | Poste | Début |
|---|---|---|
Cardio, Inc. | Directeur/Membre du Conseil | 15/07/2009 |
Daiwa Corporate Investment Co., Ltd.
 Daiwa Corporate Investment Co., Ltd. Investment ManagersFinance Daiwa Corporate Investment invests in companies located in Japan. The firm focuses on a broad range of sectors and Industries. It participates in buyout, early and growth stage transactions. | Private Equity Investor | 01/04/2022 |
Anciens postes connus de Hiroki Narita
| Sociétés | Poste | Fin |
|---|---|---|
| RAQUALIA PHARMA INC. | Directeur/Membre du Conseil | 31/10/2011 |
TMRC Co. Ltd.
 TMRC Co. Ltd. BiotechnologyHealth Technology Operates as a pharma company that researches and develops anti-cancer drugs | Directeur/Membre du Conseil | - |
Daiwa SMBC Capital Co., Ltd.
 Daiwa SMBC Capital Co., Ltd. Investment ManagersFinance Engages in private equity investments | Corporate Officer/Principal | - |
| RIBOMIC INC. | Directeur/Membre du Conseil | - |
REGiMMUNE Corp.
 REGiMMUNE Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops immune medicines | Directeur/Membre du Conseil | - |
Formation de Hiroki Narita
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
41
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Daiwa SMBC Capital Co., Ltd.
Daiwa SMBC Capital Co., Ltd. Investment ManagersFinance Engages in private equity investments | Finance |
Aoyama Gakuin University
 Aoyama Gakuin University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
REGiMMUNE Corp.
REGiMMUNE Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops immune medicines | Health Technology |
TMRC Co. Ltd.
TMRC Co. Ltd. BiotechnologyHealth Technology Operates as a pharma company that researches and develops anti-cancer drugs | Health Technology |
Ribomic, Inc.
 Ribomic, Inc. Pharmaceuticals: MajorHealth Technology Manufactures aptamer drug | Health Technology |
Cardio, Inc. | |
Daiwa Corporate Investment Co., Ltd.
Daiwa Corporate Investment Co., Ltd. Investment ManagersFinance Daiwa Corporate Investment invests in companies located in Japan. The firm focuses on a broad range of sectors and Industries. It participates in buyout, early and growth stage transactions. | Finance |
RaQualia Pharma, Inc.
 RaQualia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development of medicines | Health Technology |
